BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13704240)

  • 1. [The content of copper in the tissues of the brain in normal conditions and in various diseases of the nervous system].
    GEKHT BM
    Biull Eksp Biol Med; 1961 Feb; 51():49-54. PubMed ID: 13704240
    [No Abstract]   [Full Text] [Related]  

  • 2. [The content of copper in the tissues of patients with hepatolenticular degeneration].
    BAUMAN LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():1141-5. PubMed ID: 13687972
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the localization of copper in the brain in hepatolenticular degeneration].
    Levina GIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):990-3. PubMed ID: 4175278
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of drugs upon the copper metabolism in hepatolenticular degeneration and in normal subjects.
    ZIMDAHL WT; HYMAN I; STAFFORD WF
    J Lab Clin Med; 1954 May; 43(5):774-84. PubMed ID: 13163577
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of copper metabolism on neurological functions in Wistar and Wilson's disease model rats.
    Fujiwara N; Iso H; Kitanaka N; Kitanaka J; Eguchi H; Ookawara T; Ozawa K; Shimoda S; Yoshihara D; Takemura M; Suzuki K
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1079-86. PubMed ID: 16970921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histochemical demonstration of copper in a case of hepatolenticular degeneration.
    GREEN CL
    Am J Pathol; 1955; 31(3):545-53. PubMed ID: 14376512
    [No Abstract]   [Full Text] [Related]  

  • 7. [Copper in hepatolenticular degeneration (H.L.D.)].
    Pardo R; Rubio HH
    Acta Gastroenterol Latinoam; 1971; 3(1):27-8. PubMed ID: 5135751
    [No Abstract]   [Full Text] [Related]  

  • 8. [The behavior of serum copper and p-polyphenoloxydase activity in clinical and subclinical forms of hepatolenticular diseases].
    GASTAGER H; HORNYKIEWICZ O; TSCHABITSCHER H
    Wien Z Nervenheilkd Grenzgeb; 1954; 9(3):312-9. PubMed ID: 13205990
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatolenticular degeneration. Present status of chemical pathology and treatment. I. Normal metabolism of copper and disorder of copper metabolism in hepatolenticular degeneration].
    BOUDIN G; PEPIN B
    Presse Med (1893); 1962 Apr; 70():1027-30. PubMed ID: 13871780
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental studies on the pathogenesis of hepatogenic encephalopathy.
    Mossakowski MJ
    Riv Patol Nerv Ment; 1978; 99(1):25-36. PubMed ID: 752896
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on hepatocerebral disease. III. Hepatolenticular degeneration in Japan, with studies on copper metabolism.
    OKINAKA S
    Neurology; 1961 Sep; 11():792-9. PubMed ID: 13730604
    [No Abstract]   [Full Text] [Related]  

  • 12. Copper in Alzheimer's disease: too much or too little?
    Quinn JF; Crane S; Harris C; Wadsworth TL
    Expert Rev Neurother; 2009 May; 9(5):631-7. PubMed ID: 19402774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper storage in hepatolenticular degeneration and allied diseases.
    CUMINGS JN
    Proc R Soc Med; 1954 Feb; 47(2):152-4. PubMed ID: 13134199
    [No Abstract]   [Full Text] [Related]  

  • 14. Reaction of brain copper proteins with sodium diethyldithiocarbamate in normal and in hepatolenticular degeneration.
    PORTER H; AINSWORTH S
    Proc Soc Exp Biol Med; 1958 Jun; 98(2):277-80. PubMed ID: 13554617
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper.
    Lindquist RR
    Arch Pathol; 1969 Apr; 87(4):370-9. PubMed ID: 5766764
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on copper metabolism. XIII. Hepatolenticular degeneration.
    CARTWRIGHT GE; HODGES RE; GUBLER CJ; MAHONEY JP; DAUM K; WINTROBE MM; BEAN WB
    J Clin Invest; 1954 Nov; 33(11):1487-501. PubMed ID: 13211803
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum and urinary copper levels in healthy humans and in certain pathologic conditions.
    Lyko J
    Acta Med Pol; 1965; 6(3):389-95. PubMed ID: 5841171
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of distribution of copper inside and outside of lysosomes in cultured hepatolenticular degeneration fibroblasts by electron probe X-ray microanalysis.
    Liu W; Li JY; Jin J; Zuo J
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):270-3. PubMed ID: 14599982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of copper in hepatolenticular degeneration.
    ZIMDAHL WT; HYMAN I; COOK ED
    Neurology; 1953 Aug; 3(8):569-76. PubMed ID: 13087576
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cerebral copper-protein complexes in hepatolenticular degeneration studied by means of electron spin resonance].
    Wender M; Adamczewska Z; GruszczyƄska U; Dezor A
    Neurol Neurochir Pol; 1974; 8(5):677-9. PubMed ID: 4372575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.